E-LIB Suche - Ergebnisse für: Theile, Susann - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Phase 2 study of ipilimumab, nivolumab, and tocilizumab com..:

Chen, Inna M. ; Donia, Marco ; Chamberlain, Christopher A....
European Journal of Cancer. 180 (2023) - p. 125-133 , 2023

Link: https://doi.org/10.1016/..

2

Plasma YKL-40 is associated with prognosis in patients with..:

Johansen, Astrid Z. ; Novitski, Sif I. ; Hjaltelin, Jessica X....
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Randomised phase II trial of stereotactic body radiotherapy..:

Spindler, Nicklas Juel ; Persson, Gitte Fredberg ; Theile, Susann...
BMJ Open. 13 (2023) 1 - p. e063500 , 2023

Link: https://doi.org/10.1136/..

4

Molecular response patterns in relapsed/refractory AML pati..:

Klement, Piroska ; Fiedler, Walter ; Gabdoulline, Razif...
Annals of Hematology. 102 (2022) 2 - p. 323-328 , 2022

Link: https://doi.org/10.1007/..

5

A Randomized Placebo-Controlled Phase 2 Study of Gemcitabin..:

Theile, Susann ; Johansen, Julia Sidenius ; Nielsen, Dorte Lisbet...
Pharmaceutics. 14 (2022) 3 - p. 509 , 2022

Link: https://doi.org/10.3390/..

6

COLAR: open-label clinical study of IL-6 blockade with toci..:

Holmstroem, Rikke Boedker ; Nielsen, Ole Haagen ; Jacobsen, Søren...
Journal for ImmunoTherapy of Cancer. 10 (2022) 9 - p. e005111 , 2022

Link: https://doi.org/10.1136/..

7

A Phase II study of selinexor plus cytarabine and idarubici..:

Fiedler, Walter ; Chromik, Joerg ; Amberg, Stefanie...
British Journal of Haematology. 190 (2020) 3 - p. , 2020

Link: https://doi.org/10.1111/..

8

Cancer patients, physicians, and nurses differ in their att..:

Saltbæk, Lena ; Michelsen, Hanne M. ; Nelausen, Knud M....
Supportive Care in Cancer. 28 (2020) 12 - p. 6057-6066 , 2020

Link: https://doi.org/10.1007/..

9

Randomised phase II trial of stereotactic body radiotherapy..:

Spindler, Nicklas Juel ; Persson, Gitte Fredberg ; Theile, Susann...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887717/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Plasma YKL-40 is associated with prognosis in patients with..:

Johansen, Astrid Z ; Novitski, Sif I ; Hjaltelin, Jessica X...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513102/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Effects of a 12-Week Multimodal Exercise Intervention Among..:

Mikkelsen, Marta K ; Lund, Cecilia M ; Vinther, Anders...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842365/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Molecular response patterns in relapsed/refractory AML pati..:

Klement, Piroska ; Fiedler, Walter ; Gabdoulline, Razif...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889470/. , 2022

Link: http://www.ncbi.nlm.nih...

13

COLAR: open-label clinical study of IL-6 blockade with toci..:

Holmstroem, Rikke Boedker ; Nielsen, Ole Haagen ; Jacobsen, Søren...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472120/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Plasma YKL-40 is associated with prognosis in patients with..:

Astrid Z. Johansen ; Sif I. Novitski ; Jessica X. Hjaltelin...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228907/full. , 2023

Link: https://doi.org/10.3389/..

15

DataSheet_1_Plasma YKL-40 is associated with prognosis in p..:

Astrid Z. Johansen ; Sif I. Novitski ; Jessica X. Hjaltelin...
doi:10.3389/fimmu.2023.1228907.s001. , 2023

Link: https://doi.org/10.3389/..

1-15